Bias due to withdrawal in long-term randomised trials in COPD: Evidence from the TORCH study-Reference-Cited by-同舟云学术

Bias due to withdrawal in long-term randomised trials in COPD: Evidence from the TORCH study

Published:2010-12-15 Issue:1 Volume:5 Page:44-49
ISSN:1752-6981
Container-title:The Clinical Respiratory Journal
language:en
Short-container-title:

Author:

Vestbo Jørgen,Anderson Julie Anne,Calverley Peter Mark Anthony,Celli Bartolomé,Ferguson Gary Thomas,Jenkins Christine,Yates Julie Carol,Jones Paul Wyatt

Publisher

Wiley

Subject

Genetics(clinical),Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1752-699X.2010.00198.x/fullpdf

Reference20 articles.

1. Fundamentals of Clinical Trials

2. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study;Wood;BMJ.,2008

3. The TORCH (Towards a Revolution in COPD Health) survival study protocol;Vestbo;Eur Respir J.,2004

4. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease;Calverley;N Engl J Med.,2007

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply: Simplifying pharmacotherapy for patients with COPD: a viewpoint;European Respiratory Journal;2023-12

2. Simplifying pharmacotherapy for patients with COPD: a viewpoint;European Respiratory Journal;2023-12

3. Pharmacotherapy and Mortality in Chronic Obstructive Pulmonary Disease;American Journal of Respiratory and Critical Care Medicine;2022-11-15

4. Computer clinical decision support that automates personalized clinical care: a challenging but needed healthcare delivery strategy;Journal of the American Medical Informatics Association;2022-09-19

5. The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset;International Journal of Chronic Obstructive Pulmonary Disease;2022-08